Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma

•GPC4 gene polymorphisms were associated with susceptibility to EBVaGC.•Allele of GPC4 associated with susceptibility to EBVaGC.•The T allele of GPC4 may be the risk factor for EBVaGC. Gastric cancer (GC) is one of the most common malignant tumors in China and single nucleotide polymorphisms (SNPs)...

Full description

Saved in:
Bibliographic Details
Published in:Virus research Vol. 220; pp. 52 - 56
Main Authors: Zhao, Danrui, Liu, Shuzhen, Sun, Lingling, Zhao, Zhenzhen, Liu, Song, Kuang, Xiaojing, Shu, Jun, Luo, Bing
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 15-07-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•GPC4 gene polymorphisms were associated with susceptibility to EBVaGC.•Allele of GPC4 associated with susceptibility to EBVaGC.•The T allele of GPC4 may be the risk factor for EBVaGC. Gastric cancer (GC) is one of the most common malignant tumors in China and single nucleotide polymorphisms (SNPs) have been found to be highly related to GC carcinogenesis. Glypican-4 (GPC4), a member of the heparan sulphate proteoglycan family, plays an important role in the regulation of cell growth and differentiation. However, little is known about polymorphisms of GPC4 gene and their associated susceptibility to GC, especially to Epstein-Barr virus-associated GC (EBVaGC). Here we studied the GPC4 polymorphism (rs1048369) in GC individuals, especially those with EBVaGC, and we explored an association between the GPC4 gene polymorphism (rs1048369) and susceptibility to EBVaGC and Epstein-Barr virus-negative GC (EBVnGC) in a population from Northern China. The GPC4 gene polymorphism (rs1048369) was detected in 54 cases of EBVaGC and 73 cases of EBVnGC using polymerase chain reaction (PCR). One hundred and seven peripheral blood samples from healthy individuals were also measured as a control group. There were significant differences in both the genotype and allelic frequency of GPC4 gene (rs1048369) between the EBVaGC and EBVnGC patients. Meanwhile, the distribution of genotype and allelic frequency of GPC4 (rs1048369) differed between EBVaGC and control groups. Distribution of the GPC4 genotype also revealed differences between EBVnGC and control groups, no significant differences in the allelic frequency of the GPC4 gene (rs1048369) were observed. The frequency of the T allele in EBVaGC group was significantly higher than that in control and EBVnGC groups. The GPC4 gene polymorphism and the allele of GPC4 are both associated with susceptibility to EBVaGC. The T allele of GPC4 may represent a risk factor for EBVaGC.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-1702
1872-7492
DOI:10.1016/j.virusres.2016.04.005